Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mc Egea Estopinan"'
Autor:
S Fernandez-Perez, Mc Egea Estopinan, M Satue Palacian, Elena García-Martín, M Bambo, M Ara Gabarre, R Herrero Latorre, G De La Mata Perez
Publikováno v:
Acta Ophthalmologica. 90
Purpose To present a case report of a patient with congenital glaucoma and megalocornea, who suffer iris desinsertion and crystalline luxation during adulthood. Methods We present a 46-year-old male with bilateral congenital glaucoma treated with bil
Autor:
S. Valle, Mc Egea Estopinan, N Guerri Monclus, P. Ventura, H. Tuquet, V Pueyo Royo, E Prieto, Daniel Oros
Publikováno v:
Acta Ophthalmologica. 88
Purpose Evaluate the influence of intrauterine exposure to tobacco in the development of visual function and the retinal nerve fiber layer (RNFL) in school-age children. Methods Retrospective cohort study with children from 5 to 14 years old. The stu
Autor:
Mc Egea Estopinan, Miriam Idoipe, Isabel Pinilla, Elena García-Martín, N Guerri Monclus, Isabel Fuertes, S Fernandez Perez, O Ruiz Moreno, E Prieto Calvo, N Cruz
Publikováno v:
Acta Ophthalmologica. 88
Purpose Multiple evanescent white dot syndrome (MEWDS) is included in the “White dots syndroms” group. It is characterized for the presence of small, flat, multifocal, gray-white lesions ranging in size from 100-300 µm at external retina or as d
Autor:
Elena García-Martín, Mc Egea Estopinan, S Otin, S Fernandez, Paco Calvo, Antonio Ferreras, Miriam Idoipe, N Guerri Monclus, L Gil Arribas, E Prieto, I Altemir
Publikováno v:
Acta Ophthalmologica. 88
Purpose To compare the results obtained between Humphrey Perimeter (Carl Zeiss Meditec, EEUU) and Heidelberg Edge Perimeter (HEP, Heidelberg Engineering, Alemania) tested in a group of glaucomatous patients. Methods A total of 23 eyes of 23 glaucomat
Autor:
Paco Calvo, N Guerri Monclus, L Gil Arribas, E Prieto, Miriam Idoipe, S Fernandez Perez, E Garcia Martin, Mc Egea Estopinan
Publikováno v:
Acta Ophthalmologica. 88
Purpose To evaluate the evolution of the visual field defects and the alterations of the retinal nerve fiber layer (RNFL), which are produced in intracranial neoplasms that affect the visual pathway. Methods Description of a clinical case. 44 years o
Autor:
Miriam Idoipe, S Fernandez Perez, Isabel Pinilla, E. Borque Rodríguez-Maimon, N Guerri Monclus, Isabel Fuertes, N Cruz, Mc Egea Estopinan, Elena García-Martín, E Prieto Calvo
Publikováno v:
Acta Ophthalmologica. 88
Purpose To compare optic nerve and macular thickness in patientes with Diabetes Mellitus (DM) type 1 without retinopathy, with healthy subjects. Methods Comparative cross-sectional study. One eye per patient was randomly selected from fifty healthy s
Autor:
V Pueyo Royo, P Calvo Perez, L Gil Arribas, Mc Egea Estopinan, Fj Fernandez Tirado, M Idoipe Corta, G De La Mata Perez, N Guerri Monclus, S Fernandez Perez
Publikováno v:
Acta Ophthalmologica. 88
Purpose A case report of a 44-year-old woman with severe graves’ orbitopathy treated with high-dose intravenous glucocorticoids, radiotherapy and bilateral orbital decompression by endoscopic surgery. Methods In the initial examination the correcte
Publikováno v:
Acta Ophthalmologica. 87
Purpose Ocular metastases are becoming less and less rare. Choroidal metastases are recognized as the most common intraocular malignancy. Most ocular tumors metastasize from systemic origins in breast carcinoma in females, and bronchial carcinoma in
Publikováno v:
Acta Ophthalmologica. 87
Purpose The central serous chorioretinopathy (CSCR) is a frequent ocular disease characterized by a serous detachment of the neurosensory retina at the posterior pole. This sporadic and self-finished disease can become chronical in some cases, result
Autor:
N Guerri Monclus, E Ferrer Novella, C Torrón Fernández-Blanco, Mc Egea Estopinan, O Ruiz Moreno, E Prieto Calvo, L.E. Pablo
Publikováno v:
Acta Ophthalmologica. 87
Purpose To evaluate the efficacy of intravitreal Ranibizumab as treatment for choroidal neovascularisation due to pathological myopia Methods A retrospective, non-comparative study of 21 eyes treated with intravitreal injections of Ranibizumab. Ten e